Renal Outcome with Eculizumab in Patients with aHUS with Native and Transplanted Kidneys: Pooled Analysis of 100 Patients.

C. Legendre; Josep M. Campistol; Thorsten Feldkamp; J Wang; Giuseppe Remuzzi; Laurent Weekers; N. Sheerin

Related publications

Article2017

Outcomes of patients with atypical haemolytic uraemic syndrome with native and transplanted kidneys treated with eculizumab: a pooled<i>post hoc</i>analysis

Christophe Legendre, Josep M. Campistol, Thorsten Feldkamp, Giuseppe Remuzzi, John Kincaid, Åsa Lommelé, Jimmy Wang, Laurent Weekers, Neil Sheerin

Article2021

Iptacopan, a Novel Oral Complement Factor B (FB) Inhibitor, Significantly Reduces Proteinuria and C3 Deposit Scores in Native and Transplanted Kidneys C3 Glomerulopathy (C3G) Patients

Edwin Wong, Carla Nester, Teresa Cavero, Alexandre Karras, Moglie Lequintrec-Donnette, Liz Lightstone, Ute Eisenberger, María José Soler, Andrea Biondani, Frédérique Chaperon, Kenneth Kulmatycki, Julie M. Milojevic, Prasanna Kumar Nidamarthy, Nicholas J.A. Webb, G. Junge, Giuseppe Remuzzi

Article2014

Dynamics of complement activation in aHUS and how to monitor eculizumab therapy

Marina Noris, Miriam Galbusera, Sara Gastoldi, Paolo Macor, Federica Banterla, Elena Bresin, Claudio Tripodo, Serena Bettoni, Roberta Donadelli, Elisabetta Valoti, Francesco Tedesco, Alessandro Amore, Rosanna Coppo, Piero Ruggenenti, Eliana Gotti, Giuseppe Remuzzi

Article2014

Renal Bioengineering with Scaffolds Generated from Rat and Pig Kidneys

Marina Figliuzzi, Giuseppe Remuzzi, Andrea Remuzzi

Article2021

Systolic blood pressure and outcome in patients admitted with acute heart failure: a pooled analysis from 4 randomized clinical trials

Johannes Grand, Kristina Miger, Ahmad Sajadieh, Lars Køber, Christian Torp‐Pedersen, Georg Ertl, JL. Lopez Sendon, Aldo Maggioni, Olav Wendelboe Nielsen